Sun Pharma reported consolidated revenue growth of 15.2% for Q3 FY27, led by its Shipbuilding division, which contributed 12.5% of the total. Operating margin held at 8.3%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.

Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $286 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.

The numbers

Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 12.5% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.

Capital expenditure guidance was raised to $1.8 billion for the fiscal year, from $286 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 8.3% more output without additional land.

The company also announced a new facility near Kandla, designed to add about 1,932 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.

“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”

Expansion and capital allocation

Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.

On the post-results call, management said the order book now stands at $1.8 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in South Korea and Saudi Arabia. The chief financial officer described visibility as the best in five years.

Customers, contracts and exports

Export performance was a bright spot. Shipments to South Korea rose 15.2%, helped by certification wins and shorter lead times from Kandla. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.

Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2030, and disclosed that 12.5% of electricity at its main sites now comes from renewable sources under long-term contracts.

Risks and analyst view

Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.